top of page
  • Writer's pictureBarry Laird

MENAC Breaking Results - ASCO2024

CCC member Tora Solheim will be presenting the results from a randomised, open-label trial of a multimodal intervention (exercise, nutrition and anti-inflammatory medication) plus standard care versus standard care alone to attenuate cachexia in patients with advanced cancer undergoing chemotherapy in an oral presentation at ASCO 2024.


Recent Posts

See All

Cachexia Trials Endpoints Reviews Series

The CCC in collaboration with an international group of experts in cachexia research are undertaking a series of extensive systematic reviews examining endpoints in cachexia clinical trials. Thus far


bottom of page